IBDEI34W ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50054,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,50054,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,50055,0)
 ;;=L30.0^^193^2487^270
 ;;^UTILITY(U,$J,358.3,50055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50055,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,50055,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,50055,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,50056,0)
 ;;=L30.1^^193^2487^143
 ;;^UTILITY(U,$J,358.3,50056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50056,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,50056,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,50056,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,50057,0)
 ;;=L30.2^^193^2487^135
 ;;^UTILITY(U,$J,358.3,50057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50057,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,50057,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,50057,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,50058,0)
 ;;=L30.4^^193^2487^147
 ;;^UTILITY(U,$J,358.3,50058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50058,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,50058,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,50058,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,50059,0)
 ;;=L30.8^^193^2487^138
 ;;^UTILITY(U,$J,358.3,50059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50059,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,50059,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,50059,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,50060,0)
 ;;=L30.9^^193^2487^139
 ;;^UTILITY(U,$J,358.3,50060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50060,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,50060,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,50060,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,50061,0)
 ;;=L40.0^^193^2487^293
 ;;^UTILITY(U,$J,358.3,50061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50061,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,50061,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,50061,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,50062,0)
 ;;=L40.1^^193^2487^296
 ;;^UTILITY(U,$J,358.3,50062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50062,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,50062,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,50062,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,50063,0)
 ;;=L40.2^^193^2487^12
 ;;^UTILITY(U,$J,358.3,50063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50063,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,50063,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,50063,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,50064,0)
 ;;=L40.3^^193^2487^295
 ;;^UTILITY(U,$J,358.3,50064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50064,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,50064,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,50064,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,50065,0)
 ;;=L40.4^^193^2487^160
 ;;^UTILITY(U,$J,358.3,50065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50065,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,50065,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,50065,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,50066,0)
 ;;=L40.8^^193^2487^292
 ;;^UTILITY(U,$J,358.3,50066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50066,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,50066,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,50066,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,50067,0)
 ;;=L40.9^^193^2487^294
 ;;^UTILITY(U,$J,358.3,50067,1,0)
 ;;=^358.31IA^4^2
